Multivariate survival analysis of children with medulloblastoma - A single-center experience

Shih Hsiang Chen, Li Yu Liu, Tang Her Jaing, Chen Kan Tseng, Kuang Lin Lin, Tai Ngar Lui

Research output: Contribution to journalArticle

Abstract

The authors sought to evaluate the treatment outcome of children with medulloblastoma at a single institution. Forty-two children were analyzed. Eighty-six percent of the children who received chemotherapy were treated with cisplatin-based chemotherapy. No factors were found to affect outcome significantly. Compared with children treated before 1994 at the same institution, the median survival time was significantly longer (40 vs. 25 months, p =.0003). The authors conclude that some improvement of treatment outcome for children with medulloblastoma seemed to be achieved.

Original languageEnglish
Pages (from-to)647-654
Number of pages8
JournalPediatric Hematology and Oncology
Volume25
Issue number7
DOIs
Publication statusPublished - Sep 2008
Externally publishedYes

Fingerprint

Medulloblastoma
Survival Analysis
Multivariate Analysis
Drug Therapy
Cisplatin

Keywords

  • Children
  • Medulloblastoma
  • Outcome
  • Survival
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Multivariate survival analysis of children with medulloblastoma - A single-center experience. / Chen, Shih Hsiang; Liu, Li Yu; Jaing, Tang Her; Tseng, Chen Kan; Lin, Kuang Lin; Lui, Tai Ngar.

In: Pediatric Hematology and Oncology, Vol. 25, No. 7, 09.2008, p. 647-654.

Research output: Contribution to journalArticle

Chen, Shih Hsiang ; Liu, Li Yu ; Jaing, Tang Her ; Tseng, Chen Kan ; Lin, Kuang Lin ; Lui, Tai Ngar. / Multivariate survival analysis of children with medulloblastoma - A single-center experience. In: Pediatric Hematology and Oncology. 2008 ; Vol. 25, No. 7. pp. 647-654.
@article{900f0f5eb61141a98d2be5a503f4f53d,
title = "Multivariate survival analysis of children with medulloblastoma - A single-center experience",
abstract = "The authors sought to evaluate the treatment outcome of children with medulloblastoma at a single institution. Forty-two children were analyzed. Eighty-six percent of the children who received chemotherapy were treated with cisplatin-based chemotherapy. No factors were found to affect outcome significantly. Compared with children treated before 1994 at the same institution, the median survival time was significantly longer (40 vs. 25 months, p =.0003). The authors conclude that some improvement of treatment outcome for children with medulloblastoma seemed to be achieved.",
keywords = "Children, Medulloblastoma, Outcome, Survival, Treatment",
author = "Chen, {Shih Hsiang} and Liu, {Li Yu} and Jaing, {Tang Her} and Tseng, {Chen Kan} and Lin, {Kuang Lin} and Lui, {Tai Ngar}",
year = "2008",
month = "9",
doi = "10.1080/08880010802243979",
language = "English",
volume = "25",
pages = "647--654",
journal = "Pediatric Hematology and Oncology",
issn = "0888-0018",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Multivariate survival analysis of children with medulloblastoma - A single-center experience

AU - Chen, Shih Hsiang

AU - Liu, Li Yu

AU - Jaing, Tang Her

AU - Tseng, Chen Kan

AU - Lin, Kuang Lin

AU - Lui, Tai Ngar

PY - 2008/9

Y1 - 2008/9

N2 - The authors sought to evaluate the treatment outcome of children with medulloblastoma at a single institution. Forty-two children were analyzed. Eighty-six percent of the children who received chemotherapy were treated with cisplatin-based chemotherapy. No factors were found to affect outcome significantly. Compared with children treated before 1994 at the same institution, the median survival time was significantly longer (40 vs. 25 months, p =.0003). The authors conclude that some improvement of treatment outcome for children with medulloblastoma seemed to be achieved.

AB - The authors sought to evaluate the treatment outcome of children with medulloblastoma at a single institution. Forty-two children were analyzed. Eighty-six percent of the children who received chemotherapy were treated with cisplatin-based chemotherapy. No factors were found to affect outcome significantly. Compared with children treated before 1994 at the same institution, the median survival time was significantly longer (40 vs. 25 months, p =.0003). The authors conclude that some improvement of treatment outcome for children with medulloblastoma seemed to be achieved.

KW - Children

KW - Medulloblastoma

KW - Outcome

KW - Survival

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=53749105471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53749105471&partnerID=8YFLogxK

U2 - 10.1080/08880010802243979

DO - 10.1080/08880010802243979

M3 - Article

VL - 25

SP - 647

EP - 654

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

SN - 0888-0018

IS - 7

ER -